Sarepta Therapeutics Inc

11 nov. 2026, 21:06 UTC

Sarepta Therapeutics, Inc. is trading higher in Wednesday's session, recovering from an earlier decline while remaining below its 20-day moving average.

10 nov. 2026, 21:02 UTC

Sarepta Therapeutics upgraded to Hold by Deutsche Bank, with the price target raised to $18 from $14, despite a significant decline in stock price today.

9 nov. 2026, 23:06 UTC

Sarepta Therapeutics, Inc. shares advanced modestly in after-market hours, reaching a high that indicates a slight gain from Monday's close.

6 nov. 2026, 21:03 UTC

RBC Capital raises Sarepta Therapeutics' price target to $18.00, citing strong Q3 results with adjusted EPS of $0.13 and revenue guidance increase of $50 million.

5 nov. 2026, 23:31 UTC

Sarepta Therapeutics reported Q3 adjusted EPS of $0.13 and revenue of $381.4 million, but projected Q4 revenue at Q3 levels, raising investor concerns.

4 nov. 2026, 21:07 UTC

Sarepta Therapeutics, Inc. shares are advancing as the broader market gains momentum, settling above its 20-day moving average and near the upper end of its one-month trading range.

3 nov. 2026, 20:46 UTC

Sarepta Therapeutics, Inc. is trading higher, extending gains from Monday's close and remaining above its 20-day moving average despite a slight retracement.

2 nov. 2026, 20:36 UTC

Sarepta Therapeutics, Inc. shares fell, continuing a three-session decline.

30 oct. 2026, 23:51 UTC

Sarepta Therapeutics, Inc. is trading modestly higher in after-market hours after a strong upward movement from a low point shortly after the market closed.

29 oct. 2026, 23:21 UTC

Sarepta Therapeutics, Inc. is trading lower in after-market hours, influenced by a broader market decline despite an earlier session rebound.

28 oct. 2026, 19:46 UTC

Sarepta Therapeutics, Inc. is trading higher, reaching a peak cumulative return amid broader market strength and remaining above its 20-day moving average.

27 oct. 2026, 23:21 UTC

Sarepta Therapeutics, Inc. shares declined in after-hours trading, reaching a low shortly after the market closed before a slight recovery.

26 oct. 2026, 23:11 UTC

Sarepta Therapeutics Inc is declining in after-market trading, moving lower alongside the broader market after retracing from an earlier gain.

23 oct. 2026, 20:07 UTC

Sarepta Therapeutics Inc shares fell amid broader market losses, influenced by rising oil prices, geopolitical tensions, and mixed economic indicators.

22 oct. 2026, 20:07 UTC

Shares of Sarepta Therapeutics Inc are declining, following an early peak and midday drop.

21 oct. 2026, 23:56 UTC

Sarepta Therapeutics Inc's shares are trading higher in after-market hours, following a day of fluctuating returns with prices ranging from a high of 0.48% to a low of -1.58%.

20 oct. 2026, 20:01 UTC

Sarepta Therapeutics Inc is advancing, continuing its upward trend with gains since Monday's close, despite an earlier pullback from a session high.

16 oct. 2026, 20:07 UTC

Sarepta Therapeutics Inc shares are declining, continuing a downward trend from Thursday's close, despite new data suggesting safe administration of Elevidys to younger boys.

15 oct. 2026, 20:02 UTC

Sarepta Therapeutics presents new preclinical data on SRP-1003 at the Oligonucleotide Therapeutics Society meeting, showing promise for treating myotonic dystrophy type 1.

14 oct. 2026, 20:07 UTC

Sarepta Therapeutics presented new preclinical data showing SRP-1003 achieved approximately 80% knockdown of pathogenic DMPK RNA, advancing treatment for myotonic dystrophy type 1.

13 oct. 2026, 20:01 UTC

Sarepta Therapeutics Inc shares fell sharply, continuing a notable decline that has kept the stock well below its 20-day moving average.

12 oct. 2026, 23:11 UTC

Sarepta Therapeutics Inc shares are trading modestly higher in after-market hours, following a period of notable decline and unusual trading behavior since Monday's close.

9 oct. 2026, 20:07 UTC

Sarepta Therapeutics shares fell sharply, reaching a low mid-morning, amid broader market declines following a drop in the Michigan Consumer Sentiment Index to 46.3.

8 oct. 2026, 20:06 UTC

Sarepta Therapeutics Inc shares are advancing as the broader market rebounds, with cumulative returns exceeding 4% since Wednesday.

6 oct. 2026, 19:15 UTC

Sarepta Therapeutics Inc shares fell sharply, moving from an early gain to a significant decline and remaining below the 20-day moving average.

5 oct. 2026, 23:40 UTC

Sarepta Therapeutics Inc is trading modestly lower in after-market hours, continuing a trend of declines over the last five sessions amid broader biotechnology sector weakness.

2 oct. 2026, 19:35 UTC

Sarepta Therapeutics Inc shares fell, marking a fifth consecutive session of lower closes, amid broader market weakness contributing to a significant monthly decline.

1 oct. 2026, 23:30 UTC

Sarepta Therapeutics Inc. advanced in after-market trading, gaining ground after Thursday's close, despite being below its 20-day moving average.

30 sept. 2026, 23:30 UTC

Sarepta Therapeutics shares are trading higher in after-market hours following new data on ELEVIDYS presented at the World Muscle Society Congress.

29 sept. 2026, 19:15 UTC

Sarepta Therapeutics Inc shares fell sharply, currently trading significantly below its 20-day moving average and near the lower end of its one-month range.